N. Mirza

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.

Trey Sunderland, J. Bartko, T. Sunderland, 2003, JAMA.

Context-specific memory and apolipoprotein E (ApoE) ε4: Cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease

F. Lalonde, T. Sunderland, R. Cohen, 2004, Journal of the International Neuropsychological Society.

Decreased (cid:1) -Amyloid 1-42 and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease

J. Bartko, T. Sunderland, R. Cohen, 2003 .

Diagnosis of deep septic thrombophlebitis in cancer patients by fluorine-18 fluorodeoxyglucose positron emission tomography scanning: a preliminary report.

B. Barlogie, E. Anaissie, G. Tricot, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hippocampal atrophy in the healthy is initially linear and independent of age

T. Sunderland, R. Cohen, J. Szczepanik, 2006, Neurobiology of Aging.

Cerebrospinal fluid β-amyloid1–42 and tau in control subjects at risk for Alzheimer’s disease: The effect of APOE ε4 allele

Holly Soares, Trey Sunderland, Gyorgy Csako, 2004, Biological Psychiatry.

Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.

Holly Soares, Trey Sunderland, Gyorgy Csako, 2004, Biological psychiatry.

Effects of previous major depressive illness on cognition in Alzheimer disease patients.

T. Sunderland, R. Cohen, J. Levy, 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Development of subtle psychotic symptoms with memantine: a case report.

E. Huey, T. Sunderland, I. Dustin, 2005, The Journal of clinical psychiatry.

Stability of CSF β-Amyloid1–42 and Tau Levels by APOE Genotype in Alzheimer Patients

H. Soares, E. Huey, T. Sunderland, 2006, Dementia and Geriatric Cognitive Disorders.